Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

The Role of Health Policy and Health Insurance in Improving Cancer Prevention, Early Detection, and Treatment Services

American Cancer Society

Purpose

There is a need for research that evaluates the impact of the many changes now occurring in the healthcare system with a particular focus on cancer prevention, control, and treatment. Efforts focusing on improving access to care may also impact inequities that contribute to health disparities. Public health policy initiatives such as the federal and state marketplaces that have expanded insurance coverage, as well as Medicaid expansion in some states, create natural experiments ripe for evaluation. Research to be funded by this RFA should focus on the changes in national, state, and/or local policy and the response to these changes by healthcare systems, insurers, payers, communities, practices, and patients.

A clear understanding of these changes can help clinicians, health systems, public health and public policy professionals, patient and consumer advocates, and providers to identify and guide needed improvements in cancer prevention and control and health care and health more broadly. Findings from this research may also inform advocacy and policy development by the American Cancer Society Cancer Action Network (ACS CAN) in the context of meaningful health care reform by assessing outcomes related to the structure of the health system on availability, administrative simplicity, adequacy, and affordability of coverage, referred to as the 4 A’s, which make up the Society and Cancer Action Network's framework for reform.

Scientific Scope

We are keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems. This includes but is not limited to:

Facilitators and barriers to care;
Unintended consequences;
Differential experiences and outcomes of patients seeking or receiving care;
Best practice models for quality care; and,
Economic Impact

Specific examples of potential research areas that may be applicable include the following, organized by the 4 A’s of meaningful healthcare reform:

1. Availability

Investigate factors impacting equity in cancer prevention, diagnostic, treatment, and survivorship services across populations based on availability of health insurance coverage, type of coverage, affordability, and health care setting.
Compare and contrast access and outcomes by state to provide new knowledge pertaining to how insurance coverage or lack of coverage (including lack of expanded Medicaid coverage) impacts cancer screening, diagnostic, treatment, or palliative care services.
Evaluate the impact of expanding health insurance coverage for previously uninsured or underinsured persons.

2. Affordability

Compare and contrast variations in health insurance benefit packages (including services, Rx formularies, and cost-sharing) on health care costs and the resulting impact on cancer prevention, diagnosis, treatment, and palliative and support care services.
Examine how tobacco rating is impacting the affordability of and access to insurance coverage.
Compare and contrast changes in health risk pool distribution and their impact on health care costs, health insurance enrollment, and access pre- and post-implementation of the Affordable Care Act of 2010.
Test methods to improve the efficiency of health insurance coverage and utilization.
Compare and contrast models for improving high-quality patient-centered care such as Patient-Centered Medical Homes, Accountable Care Organizations, and patient and provider incentives to encourage guideline-concordant care.

3. Adequacy

Compare and contrast the implementation of health insurance marketplaces to assess their impact to access to needed services and choice of providers, and on the adoption and completion of cancer screening, diagnostic, treatment, and palliative and supportive care services.
Compare and contrast the transparency of key information (e.g., network providers, formularies, etc.) and the extent to which this information is provided in a consumer-friendly manner.

4. Administrative simplicity

Assess the effectiveness of strategies to educate consumers about healthcare benefits and their impact on the adoption and completion of cancer screening, diagnostics and treatment services.
Conduct dissemination and implementation research of evidence-based strategies supporting patients in overcoming administrative barriers related to health insurance to facilitate the adoption and completion of cancer screening, diagnostic, treatment or palliative and supportive care services.

Acceptable Study Designs

We encourage investigators to submit innovative proposals using an array of study designs which may include interventional or non-interventional research such as case control studies, cohort studies, clinical trials, comparative effectiveness research, dissemination and implementation research, cross-sectional studies, ecological, or mixed methods research. For example:

Mixed-method studies utilizing secondary analysis and original data collection.
Conduct primary data collection in the form of surveys, key informant interviews, focus groups or other methods to capture patient-level experiences and their perceived solutions.
Make creative use of primary and secondary data sources (such as CMS data) to capture both demographic and outcome data, establish robust databases, and create registries or methods for data standardization across large data sources

Grant Term and Budget

Awards may not exceed a period of 4 years. It is anticipated that some studies will require no more than two years to complete.

Grant awards of 4 years have maximum direct costs of $215K per year, with 10% allowable indirect costs.

Both intervention and non-intervention research is acceptable. If the study is primarily data focused, mixed methods should be utilized to collect both primary data and secondary collection, or both qualitative and quantitative data.

Specialties

Cancer

Eligibility Requirements

This RFA will use the Research Scholar Grants (RSG) mechanism. See the Research Scholar Grants section of All Grant Policies and All Grant Instructions for detailed descriptions of the ACS's priority focus on health equity research in the Clinical and Cancer Control Research Grants Program and budget instructions.

Eligibility: You ARE eligible to submit a proposal if you:

Are a faculty at a US academic institution or eligible non-profit
Are a full-time independent investigator at any career stage

Sponsor Details

Sponsor Institute/Organizations: American Cancer Society

Sponsor Type: Corporate/Non-Profit

Address: 270 Peachtree St NW, Suite 1300 Atlanta , GA 30303

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity